---
figid: PMC8006759__OTT-14-2109-g0001
figtitle: Duvelisib’s activity on PI3KD in malignant B-cells results in abrogation
  of down-stream signaling of the AKT/mTOR pathway thus inhibiting survival and chemotaxis
organisms:
- Homo sapiens
- Mus musculus
pmcid: PMC8006759
filename: OTT-14-2109-g0001.jpg
figlink: pmc/articles/PMC8006759/figure/f0001/
number: F1
caption: Duvelisib’s activity on PI3Kδ in malignant B-cells results in abrogation
  of down-stream signaling of the AKT/mTOR pathway thus inhibiting survival and chemotaxis.
  Duvelisib’s activity on PI3Kγ results in decreased production of pro-survival cytokines
  from T-cells and tumor-associated myeloid cells. Created with BioRender.com.
papertitle: 'Oral PI3K-δ,γ Inhibitor for the Management of People with Chronic Lymphocytic
  Leukemia and Small Lymphocytic Lymphoma: A Narrative Review on Duvelisib.'
reftext: Ankit Shah, et al. Onco Targets Ther. 2021;14:2109-2119.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9517462
figid_alias: PMC8006759__F1
figtype: Figure
organisms_ner:
- Mus musculus
redirect_from: /figures/PMC8006759__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8006759__OTT-14-2109-g0001.html
  '@type': Dataset
  description: Duvelisib’s activity on PI3Kδ in malignant B-cells results in abrogation
    of down-stream signaling of the AKT/mTOR pathway thus inhibiting survival and
    chemotaxis. Duvelisib’s activity on PI3Kγ results in decreased production of pro-survival
    cytokines from T-cells and tumor-associated myeloid cells. Created with BioRender.com.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ell
  - El1
  - D9Mgc46e
  - Pdpn
  - Akt1
  - IPI
---
